Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey ; volume:12 ; number:1 ; day:20 ; month:1 ; year:2012 ; pages:1-13 ; date:12.2012
BMC public health ; 12, Heft 1 (20.1.2012), 1-13, 12.2012
- Creator
-
Monteiro, Susana P.
- Contributor
-
van Dijk, Liset
Verstraete, Alain G.
Álvarez, F Javier
Heissing, Michael
de Gier, Johan J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-12-59
- URN
-
urn:nbn:de:1111-2016081418990
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Monteiro, Susana P.
- van Dijk, Liset
- Verstraete, Alain G.
- Álvarez, F Javier
- Heissing, Michael
- de Gier, Johan J.
- SpringerLink (Online service)
Other Objects (12)
Evaluating patients’ perceptions regarding generic medicines in Jordan
The use of driving impairing medicines: a European survey
The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability
Traditional medicines as a mechanism for driving research innovation in Africa
An adaptive driving system regarding energy-efficiency and safety
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures
Estimating multi-country VAR models
Multicountry and Regional Macroeconometric Models
Network medicines™
Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
Electro-chemo-mechanical manipulations of clays regarding the clogging during EPB-tunnel driving
Evaluating patients’ perceptions regarding generic medicines in Jordan
The use of driving impairing medicines: a European survey
The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability
Traditional medicines as a mechanism for driving research innovation in Africa
An adaptive driving system regarding energy-efficiency and safety
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures
Estimating multi-country VAR models
Multicountry and Regional Macroeconometric Models
Network medicines™
Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
Electro-chemo-mechanical manipulations of clays regarding the clogging during EPB-tunnel driving
Evaluating patients’ perceptions regarding generic medicines in Jordan
The use of driving impairing medicines: a European survey
The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability
Traditional medicines as a mechanism for driving research innovation in Africa
An adaptive driving system regarding energy-efficiency and safety
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures
Estimating multi-country VAR models
Multicountry and Regional Macroeconometric Models
Network medicines™
Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?